ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: PO0527

Assessment of Vascular Calcification Using Micro-CT Quantification in a Vitamin D Rat Model

Session Information

Category: Bone and Mineral Metabolism

  • 401 Bone and Mineral Metabolism: Basic

Authors

  • Bassissi, Firas, Sanifit Therapeutics, Palma, Balearic Islands, Spain
  • Sabador, David, Centro Nacional de Investigaciones Oncologicas, Madrid, Madrid, Spain
  • Blasco Ferrer, Marc, Sanifit Therapeutics, Palma, Balearic Islands, Spain
  • Garaulet Perez, Guillermo, Centro Nacional de Investigaciones Oncologicas, Madrid, Madrid, Spain
  • Perez, Maria del mar, Sanifit Therapeutics, Palma, Balearic Islands, Spain
  • Ferrer, Miquel D., Sanifit Therapeutics, Palma, Balearic Islands, Spain
  • Mulero, Francisca, Centro Nacional de Investigaciones Oncologicas, Madrid, Madrid, Spain
  • Salcedo, Carolina, Sanifit Therapeutics, Palma, Balearic Islands, Spain
Background

Micro-computed tomography (micro-CT) scanning could be an alternative technique of both visualization and quantification of calcium content in vessels. Our aim was to standardize the micro-CT calcium quantification methodology and evaluate its reliability in a rat model of calcification.

Methods

Six Sprague-Dawley rats were induced by three consecutively daily subcutaneous administrations of 150 klU/kg vitamin D3 and sacrificed 5 days after induction. Three of the rats were subcutaneously treated with 60 mg/kg SNF472 (G1), an inhibitor of calcification, and the rest were treated with saline (G2). One additional rat was not induced nor treated and served as negative control. Micro-CT was performed in aorta and femoral arteries with an isotropic resolution of 45 µm, 400 projections collected in one full rotation of the gantry in 10 min, x-ray tube at 80 kV and 150 µA. A phantom made of a laser cut aluminum skeleton was scanned with the same protocol to simulate bone. After the image analysis, the vessel samples were digested (1:1 HNO3:HClO4) and total calcium was quantified using an inductively coupled plasma atomic emission spectrometry (ICP-AES).

Results

The threshold for calcium detection was established at 153.8 Hounsfield Units (HU). Rats treated with vitamin D presented more calcium deposits than the control and SNF472 treated rats (7.6 ± 6.1 HU in G2 vs 3.3 ± 3.2 HU in G1). The volume of calcium deposits in femoral samples was similar between groups. The quantification of calcium by ICP-AES brought similar results in aorta (>50% inhibition with SNF472 treatment) but not in femoral samples, as in this tissue increased calcium content was quantified in vitamin D-treated rats when compared to the control rat. A significant correlation was obtained between the calcium deposits quantified by micro-CT and the total calcium quantified by ICP-AES.

Conclusion

The threshold-based quantification method by micro-CT can be a useful and reliable tool to evaluate vascular calcification and the efficacy of inhibitors of vascular calcification in rat models, especially in large-diameter vessels such as aorta.

Funding

  • Commercial Support –